Skip to main content
SpringerLink
Log in

Soins palliatifs

  • Chapter
Les cancers digestifs

Part of the book series: Oncologie Pratique ((ONCOLPRAT))

  • 319 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. ANAES (2003) Modalités de prise en charge de l’adulte nécessitant des soins palliatifs. Med Palliat 2: 119–35

    Google Scholar 

  2. Albe Fessard D (1996) Cas particulier des douleurs viscérales. In: La Douleur, ses mécanismes et les bases de traitements. Masson, Paris: 119–28

    Google Scholar 

  3. Janig W (1984) Neurophysiological mechanisms of cancer pain. In: Recent results in cancer research (Zimmermann M, Drings P and Wagner) G. Ed. Springer-Verlag: 44–58

    Google Scholar 

  4. Standards, Options et Recommandations 2002 pour les traitements antalgiques médicamenteux des douleurs cancéreuses par excès de nociception chez l’adulte, mise à jour du rapport original de 1996 (rapport abrégé) (2002). Bull Cancer 89: 1067–74

    Google Scholar 

  5. ANON (2002) Décret n° 2002-194 du 11 février 2002 relatif aux actes professionnels et à l’exercice de la profession d’infirmier. Journal officiel de la République française

    Google Scholar 

  6. Kappis M (1919) Sensibilitat und lokale anesthesie in chirurgischen gebeit der blauchkolle mit besonderer berucksichtigung der splanchnicus anesthesie. Beitr Klin Chir 115: 161–75

    Google Scholar 

  7. Moore DC (1965) Spinal (subarachnoid) block with absolute alcohol. In: Regional block, a hand book for use in the clinical practice of medicine and surgery. Charles C, Thomas Ed, 329–36

    Google Scholar 

  8. Ischia S, Polati E, Finco G, Gottin L (2000) Celiac block for the treatment of pancreatic pain. Cur Rev Pain 4: 127–33

    CAS  Google Scholar 

  9. Moore DC (2001) Despite waffling and minimaxing computed tomography is optimal when performing a neurolytic plexus block in chronic pancreatitis. Regional anesthesia and pain medecine, 26(3): 285–7

    CAS  Google Scholar 

  10. Lebovits AH, Lefkowitz M (1989) Pain management of pancreatic carcinoma: a review. Pain 36,1: 1–11

    Article  CAS  PubMed  Google Scholar 

  11. Bridenbaugh LD, Moore DC, Campbell DD (1964) Management of upper abdominal cancer pain. JAMA 190: 99–102

    Google Scholar 

  12. Black A, Dwyer B (1973) Coeliac plexus block. Anesthes Intens Care 1: 315–8

    CAS  Google Scholar 

  13. Brown DL, Bulley CK, Quiel EL (1987) Neurolytic celiac plexus block for pancreatic cancer pain. Anesth Analg 66: 869–73

    CAS  PubMed  Google Scholar 

  14. Melzack R (1962) Skin sensitivity to thermal stimuli. Exp Neurol 6: 300

    Article  CAS  PubMed  Google Scholar 

  15. Nakahana (1966) Excitation and inhibition in ventrobasal thalamic neurons before ans after cutaneous input derivation. Prog Brain Res 21: 180

    Google Scholar 

  16. Gardner AM, Solomou G (1984) Relief of pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy. Ann Roy Coll Engl 66: 409–11

    CAS  Google Scholar 

  17. Emslie RG, Slavotinek AH (1972) Surgical objectives in the unresected cancer of the head of pancreas. Brit J Surg 59: 508–12

    Google Scholar 

  18. Flanigan DP, Kraft RO (1978) Continuing experience with palliative chemical splanchnicectomy. Arch Surg 113: 509–11

    CAS  PubMed  Google Scholar 

  19. Sadar ES, Cooperman AM (1974) Bilateral thoracic sympathectomy-splanchnicectomy in the treatment of intractable pain due to pancreatic carcinoma. Cleve Clin Quart 41: 185–8

    CAS  Google Scholar 

  20. Regnard CFB, Tempest S, Salamagne MH, Mignot H (1994) Cancers avancés: problèmes rencontrés et stratégies thérapeutiques. Arnette SA Paris

    Google Scholar 

  21. Twycross RG (1993) Dysphagia, dyspepsia and hiccup. In: Doyle D, Hanks G, MacDonald N (eds) Oxford Textbook of Palliative Medicine. Oxford Univ Press, Oxford, 291–99

    Google Scholar 

  22. Petroutka SJ, Snyder SH (1982) Anti-emetics: neurotransmitter receptor binding predicts therapeutic actions. Lancet 1: 658–9

    Google Scholar 

  23. Agence française de sécurité sanitaire des produits de santé (AFSSPS) (2002) Soins palliatifs: spécificit d’utilisation des médicaments courants hors antalgiques. Recommandations.

    Google Scholar 

  24. Allan SG (1993) Nausea and vomiting. In: Doyle D, Hanks G and MacDonald N (eds) Oxford Textbook of Palliative Medicine. Oxford Univ. Press, Oxford, 282–90

    Google Scholar 

  25. Jackson WC, Tavernier L (2003) Olanzapine for intractable nauséa in palliative care patients. J Palliat Med 6,2: 251–5

    Article  PubMed  Google Scholar 

  26. Ferris FD, Kerr IG, Sone M, Marcuzzi M (1991) Transdermal Scopolamine use in the control of narcotic-induced nausea. J Pain Sympt Manag 6: 389–93

    CAS  Google Scholar 

  27. Cole MRM, Robinson F, Harve L et al. (1994) Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with avanced cancer. J Pain Sympt Manag: 48–50

    Google Scholar 

  28. Sykes NP (1993) Constipation and diarrhoea. In: Doyle D, Hanks G, MacDonald N (eds) Oxford Textbook of Palliative Medicine. Oxford University Press, Oxford, p 299

    Google Scholar 

  29. Klauser AG, Muller-Lissner SA (1993) How effective is nonlaxative treatment of constipation. Pharm 47,Suppl. 1: 256–60

    Google Scholar 

  30. Messner W, Schmidt U, Hatmann M et al. (2000) Oral naloxone reverses opioïd-associated constipation. Pain 84: 105–9

    Google Scholar 

  31. Twycross RG, Harcourt JMV (1991) The use of laxatives at a palliative care centre. Palliat Med 5: 27–33

    Google Scholar 

  32. Baines M, Oliver DJ, Carter RL et al. (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet 2: 990–3

    CAS  PubMed  Google Scholar 

  33. Ripamonti C, Mercadante S, Groff L et al. (2000) Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manag 19: 23–34

    CAS  Google Scholar 

  34. Mercadante S, Ripamonti C, Casuccio A et al. (2000), Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8: 188–91

    CAS  PubMed  Google Scholar 

  35. Doyle D, Hanks GWC, MacDonald N (eds) (1999) Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press

    Google Scholar 

  36. Twycross RG (1994) Corticosteroids. In: Twycross RG, (eds) Pain Relief in Advanced Cancer. Churchill Livingston, 425–53

    Google Scholar 

  37. Feuer DJ, Broadley KE (2002) Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev

    Google Scholar 

  38. Bolly C, Vanhalewyn M (2002) Manuel de soins palliatifs à domicile. L’Harmattan, Paris

    Google Scholar 

Download references

Authors
  1. M. Luu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.-T. Gatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Guirimand
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Luu, M., Gatt, MT., Guirimand, F. (2006). Soins palliatifs. In: Les cancers digestifs. Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/2-287-30874-1_19

Download citation

  • DOI: https://doi.org/10.1007/2-287-30874-1_19

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22087-6

  • Online ISBN: 978-2-287-30874-1

Publish with us

Policies and ethics

Search

Navigation